Sleep Number FCF Margin
The Free Cash Flow Margin of Sleep Number (SNBR) as of Jul 22, 2026 is 0.22 %. In the previous year, Free Cash Flow Margin was -3.50 % — a change of -106.18% (higher).
Get this data via API
Financial Data API
FCF Margin
0.22 %
YoY
-106.18%
Last updated:
Free Cash Flow Margin of Sleep Number is 2026 0.22 % . Free Cash Flow Margin of Sleep Number was 2025 -3.50 % . It decreases by -106.18% higher compared to the previous year.
Access this data via the Eulerpool API
Sleep Number Stock analysis
What does Sleep Number do? Sleep Number Corp is an American company specialized in manufacturing and selling customizable mattresses. It was founded in 1987 by Robert Walker and JoAnn Walker and is headquartered in Minneapolis, Minnesota.
The company's business model is based on the belief that every person is unique and has different sleep needs. For this reason, Sleep Number has developed a patented technology that allows each customer to adjust their mattress individually. The company uses air chambers that allow the firmness of the mattress to be adjusted individually on each side. Customers can control this using a remote control and set their optimal sleep comfort.
The company is divided into two business segments: the consumer segment and the healthcare segment. In the consumer segment, Sleep Number mainly sells mattresses and related products such as duvets and pillows. In the healthcare segment, the company focuses on developing medical devices to help treat sleep disorders.
In recent years, the company has expanded its product offerings. Sleep Number now also offers Smart Beds equipped with sensors to monitor customers' sleep and provide recommendations for improving their sleep. In addition, the company has developed its own sleep app to make it easier for customers to monitor and optimize their sleep.
Sleep Number has become one of the leading providers of customizable mattresses in recent years. The company has its own stores across the United States and also sells its products online. Additionally, the company collaborates with various healthcare facilities to distribute its medical devices.
Overall, Sleep Number has experienced impressive growth in recent years. The company has consistently increased its revenues and was able to achieve solid growth in 2020 despite the global COVID-19 pandemic. This is primarily due to the high quality of its products and the unique technology that sets it apart from competitors.
In conclusion, Sleep Number is one of the most innovative providers of mattresses and sleep products on the market. With its unique technology, wide product range, and focus on the healthcare sector, the company has received numerous awards and recognition in recent years. It remains to be seen how the company will continue to evolve in the coming years, but one thing is certain: Sleep Number will continue to play an important role in the field of sleep. Sleep Number is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Sleep Number stock
Free Cash Flow Margin of Sleep Number is 0.22 % in 2026.
Access this data via the Eulerpool API
Margins — Sleep Number
All Key Metrics — Sleep Number
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth